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Abstract 
Review on RAD52, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
HGNC (Hugo): RAD52 
Location: 12p13.33 
DNA/RNA 
Note 
The human and murine RAD52 gene is composed 
of 12 exons.  
Kito et al. identified three RAD52 isoforms 
designated RAD52β (226 amino acids), RAD52γ 
(139 amino acids), and RAD52δ (118 amino acids) 
which were able to bind ssDNA and dsDNA much 
like reference RAD52 (RAD52α). However, these 
isoforms lacked the ability to associate with 
RAD52α (Kito et al., 1999). 
 
Thorpe and colleagues describe two splice variants 
that conferred increased homology-directed repair 
in the murine RAD52 gene RAD52∆exon4 and 
RAD52+intron8 (Thorpe et al., 2006). 
Protein 
Note 
The human RAD52 (hRAD52) protein is similar to 
the Saccharomyces cerevisiae RAD52 protein 
(ScRAD52) both structurally and biochemically. 
However the phenotypic properties of RAD52, 
particularly in mediating homologous 
recombination varies amongst the evolutionary 
spectrum. 
Description 
hRAD52 protein is comprised of 418 amino acids 
and forms a heptameric ring (Stasiak et al., 2000), 
which is mediated by the N-terminus (Ranatunga et 
al., 2001). This N-terminal portion binds ssDNA 
(Mortensen et al., 1996). 
 
 
RAD52 (RAD52 homolog (S. cerevisiae)) Lok BH, Powell SN 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2014; 18(10) 732 
 
Secondary structure of the hRAD52 protein. From Uniprot.org (Creative Commons License). 
 
 
The well-studied hRAD521-212 is the N-terminal 
portion which forms an undecameric ringed 
polymer (Kagawa et al., 2002).  
DNA binding properties are linked to various 
amino acids, including, Arg-55, Tyr-65, Lys-152, 
Arg-153, Arg-156. Arg-55 and Lys-152 are 
necessarily for ssDNA binding, whereas Tyr-65, 
Arg-152, and Arg-156 are essential for binding both 
ssDNA and dsDNA (Kagawa et al., 2002).  
Phe-79 and Lys-102 have also shown a role in 
ssDNA and dsDNA binding, respectively (Lloyd et 
al., 2005).  
Interfering with the Phe-79 of hRAD52 was 
recently demonstrated to disrupt the RAD52-DNA 
interaction leading to an accumulation of DNA 
double-strand breaks (DSBs) particularly in 
BRCA1/2 deficient cells (Cramer-Morales et al., 
2013).  
Further study is required to decipher the hierarchy 
of these respective sites and study additional novel 
binding sites. 
Please see the following diagram for the location of 
several of these amino acid sites. 
Localisation 
ScRAD52 is a nuclear protein and predominantly 
recruited into sub-nuclear foci during the S-phase of 
the cell cycle (Lisby et al., 2001).  
hRAD52 sub-nuclear foci formation after exposure 
to ionizing radiation is dependent on c-Abl-
mediated phosphorylation (Kitao and Yuan, 2002). 
 
 
Secondary structure of the hRAD52 protein. From Kagawa 
et al. 2002, with permission from Elsevier. 
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The hRAD521-212 undecameric polymer with principal DNA binding amino acid residues labeled residing in the predominantly 
positively charged groove. From Kagawa et al. 2002, with permission from Elsevier. 
 
 
Function 
ScRAD52 mediates RAD51 recombination activity 
and thus homology-directed repair (Milne and 
Weaver, 1993). hRAD52 also demonstrates this 
ability to stimulate homologous pairing by hRAD51 
(Benson et al., 1998). The interaction of ScRAD52 
and hRAD52 with replication protein A (RPA) is 
important for the binding with ssDNA by RAD52 
(Hays et al., 1998; Shinohara et al., 1998; Jackson 
et al., 2002). hRAD52 binds directly to DSBs, 
protects them from exonuclease resection, and 
facilitates end-to-end interaction (Van Dyck et al., 
1999). Furthermore, capture of the second DNA 
end in homologous recombination appears to 
involve RAD52-mediated annealing of RPA-
ssDNA strands in biochemical reactions (Sugiyama 
et al., 2006). 
Although, ScRAD52 and hRAD52 does not 
stimulate RAD51 DNA strand exchange with RPA-
ssDNA complexes in biochemical assays (Jensen et 
al., 2010), under certain conditions, hRAD52 does 
promote RAD51-mediated homologous DNA 
pairing (Baumann and West, 1999). 
hRAD52 mediates RAD51 recombination function 
in human cancer cells deficient in BRCA1 (Cramer-
Morales et al., 2013; Lok et al., 2013), PALB2 (Lok 
et al., 2013) or BRCA2 (Feng et al., 2011). RAD52 
is able to mediate RAD51-mediated homology-
directed repair when the predominant BRCA1-
PALB2-BRCA2 homologous recombination 
pathway is perturbed (see figure below). The 
RAD52-RAD51 pathway also appears to function 
independently of the RAD51 paralogs 
RAD51B/RAD51C/RAD51D-XRCC2 (Chun et al., 
2013). 
ScRAD52 is required for RAD51-independent 
single-strand annealing (SSA) (Singleton et al., 
2002; Symington, 2002) and break-induced 
replication (BIR) (Malkova et al., 1996; Ira and 
Haber, 2002; McEachern and Haber, 2006). 
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The BRCA and RAD52 pathways of DNA double-strand break repair. *There is currently no well-defined evidence that single-end 
DSBs or daughter-strand gaps are repaired by single strand annealing. From Lok and Powell, 2012. 
 
 
Modified from HomoloGene. 
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Mutations 
Note 
Currently, there are no known mutations of RAD52 
that lead to human disease, including none 
associated with breast cancer (Bell et al., 1999), 
ovarian cancer (Tong et al., 2003; Beesley et al., 
2007) or chronic lymphocytic leukemia (Sellick et 
al., 2008). 
Implicated in 
Resistance to platinum-based 
chemotherapy 
Prognosis 
There is a report of uncertain significance by Shi et 
al. that may link certain RAD52 variants and 
RAD52 protein expression levels to resistance to 
platinum-based chemotherapy (Shi et al., 2012), 
however no other published studies have 
demonstrated a similar association. 
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